dual glp-1/gip receptor agonists The Emerging Role of GLP-1 and GIP in Glycemic Management and Cardiovascular Risk Reduction Targeting GLP-1, GIP & GCG

GoodRx is well positioned to help pharmaceutical manufacturers sell their brands directly to patients because we already operate at the intersection of pricing transparency, patient engagement, and pharmacy fulfillment, which are the core building blocks of a DTC model. Looking ahead, Iyer said GoodRx plans to launch a GLP-1 subscription model later this year, which will streamline the process for consumers to consult with healthcare professionals, determine eligibility, and access FDA-approved medications

you can protect yourself from muscle loss by increasing your protein intake while taking GLP-1 medications

Trends: Around 64% long-acting usage, 59% weekly preference, 55% digital adoption, 52% combination therapies, 48% innovation rate, 45% monitoring integration

Importantly, a recent retrospective study had found that GLP-1 RAs reduced suicidal ideation in large cohorts of overweight or T2D patients compared to non-GLP-1R agonist anti-obesity or anti-diabetes medications [Reference Wang, Volkow, Berger, Davis, Kaelber and Xu49]

The versions of the weight loss drugs made by compounding pharmacies dont have the same approval from the U.S